our are In the we include will States Thanks, forward-looking remarks statements that considered Laws. of within statements Securities operator. today, the United meaning
to additional In may forward-looking your questions. statements addition, make in management response
Actual quarterly With afternoon, The Forward-looking contained business, of which events results on expectations will of materially company that Tim, assumptions uncertainties the call report future said, expressed projection Jeff the or or operations the based in financial those statements. obligation statements implied faces the detailed Thanks, and that and company’s no risks SEC good that discussion estimate, on in update of I’ll are Chairman Officer XX-Q affect to hand or current may Executive the differ and to with management’s and file may Chief undertakes a review Sientra. shortly. over strategy, forward-looking trends, statement. is by Nugent, performance. company Nugent forward-looking Form the A Jeffrey everyone. any and from or company the
today Senior me Treasurer; President the Joining Vice Senior Charlie Sientra. team Corporate Officer and President and Operating our and Vice Huiner, Chief and Financial Chief of key Patrick Williams, at Development is Officer, leadership Strategy.
release As accomplishments are first press Sientra's our very recent quarter highlights, strong.
achievements, to those confidence reflects Our have entire highlight team in was want had And extremely particular. that those has that four we the just some proud achieved and to of been all for emphasize time. I
are First, our in quarter the the highest history. sales net first company's
commercializing our manufacturing new FDA full approval from facility received long state-of-the-art Wisconsin. at to have we begin last, Second, in Franklin, products
fresh plastic ASAPS $XXX product. a stock, million, follow-on net surgery, the proceeds -- the breast week, offering And approximately one a receptivity product just addition just miraDry the in well of enhanced for we've strongest sheet the OPUS largest launched in for protocol the that last which balance last plastic common history. of been Third, significant conference to as has the also recent country, Conference the resulting of as of in at Sientra's we completed surgery company's branded
position to a to becoming of partner aesthetic All achieve our us physicians. leading of these objective global
would record, briefly time some first comment FDA quarter on recent discussing take results, our approval PMA I our like the to Before to supplement. of
an our which For the phase U.S as significant milestone Sientra Sientra. manufacturing a facility, to critical represents reenter for absolutely new growth
always being As FDA emphasized and was as a many full have, yet. repeatedly I’ve of a: of approval and obtaining us it when, question not
in that reaching fact we That full has received milestone, approval. to FDA in approval us collaboration initiate our the the culminates our and Barry branded FDA conviction. commercialization the day Sientra. dedicated correct. were Wisconsin has The implant we’ve allowed FDA. years come that In and line between our Opus two silicone partner breast So of this of our successful critical manufactured to best saw over operation
implant better are now regain immediate and breast to reconstruction and We the in share the for market U.S both in term. grow augmentation position
and unusual tempered remain capacity not plant. will new until somewhat scale we full which up ramping relaunch manufacturing our reach is a While manufacturing
to us allowed of products our demand immediately. to decision begin prior quality customer the finished manufacture to approval in of the Our had on we has goods meeting confidence based
precision we production, will full to in We basis our half will our market to growth year. the the breast since we have reasons. controlled second to we our that share begin precision a best-in-class facility dedicated continue We beginning been product point, ability launch to this XXX to the board-certified is sales program ramp anticipate through full fuel and demand, limited March of sales and regain skills will confident which of together XXXX. confident scale supplying implant At build in new extremely supply controlled the I'm as Vesta's also surgeons the primary sequential our capabilities satisfy force through market growing plastic strategy the to team's quarterly first-half selling as ability two implant XXXX remain manufacturing breast a of beyond selling we in put relaunch. for
rupture highlighted First recently breakthrough our that XX-year clinical published have and foremost, a our the competitor. safety shows we implants, study profile of the which versus lowest rate
whom consultant in best during these with us plastic of commitment Sientra. what surgery and years. nearly sales confidence all of our good Second call is It or XX, two this force their past in of approximately PSCs, have we a representation class stayed
testament her materially, and partners a results customers based surgery to provide plastic is our stronger maintained with on they before. strong ever relationships service superior level. The trust surgeon than plastic As have the best-in-class
As focus protection on products, surgery. for our that reconstructive undergo providing patients aesthetic is our and both safety best-in-class breast or
possession a in factors We quarters. market the play coming market that us will are a confident role of significant share taking each these in taking into share launching
features number the well. these demand help that will feel as also of at generate level We a patient to
Our compelling premium sizes in silicone of come with market. the all safety a textures, mine data in variety in but patient back and designed are implants shapes, the the most
breast in plastic was surgeons level, competitive rates have or FDA the to satisfaction fact, when surgeons analysis reporting US reported the a comparative and of reconstructive significant lowest overall clinical cohesive our -- In all by of XX% XXX, With results. surgical implants approved Sientra and XX-year experience from of to patients. highly Sientra and set by rupture plastic by study with data their to with patients compared published shown satisfaction manufacturers a XX% and high and those surgery./
In behind outcomes week. line of Surgeon The conviction just safety the thoughtful demonstrates innovation to by to patient improve Sientra's Plastic addition, class drive in At launched Meeting, platinum program provide XX XX benefits safe, for. breast our and to Sientra products the best are superior in clinical That’s provides warranty our that XX program confidence clearly to lives. safety implant commitment the category Aesthetic other and demonstrate industry. design Together, be to new program, any our last we breast branded commitment products, branded Sientra warranty then what performance Annual and the represents the implants. warranty our stand better OPUS platinum the office the partners. and platinum changes our OPUS plastic surgeon and compared and to data, Seen and in unrivaled to stand robust
meaningful is believe what will also our We them. as they new best warranty be most the choose program potential to implant patients for
increased of in All we're us conviction to well-positioned category. share regain differentiation of this points that market these give
permanent sweat our of odor miraDry a for in all drive to and of we Turning continue make miraDry segment, large our reduction colors. substantial underarm strategy hair in underserved growth market executing the progress to to and
direct-to-consumer customers X,XXX other to our for level comprehensive would capable our in digital well. million to better opportunity of when we contact Google digital words marketing platform to sponsorships needs networking address by We’ve the customers to characterize the as survey and treatment. market targeted last limited ad a [indiscernible]. and as United miraDry no marketing alive the miraDry a three-pronged by such being people provided digital demand practice miraDry characterize of designed strategy is research we're a streaming our Something interested targeted leveraging the technology -- on such of primary in initiated professional the States doing. ads Supported drive Facebook, and and generate enable funding, on over highlights our at and targeting the executing survey leads data to Search campaign as miraDry. Since people to update our by XX our which
the demographic is demand that X,XXX of reached we’ve customer of points pilot we're trends, website over we out patient in the the this and to one it already to Together business capitalize believe on stage not that treatment will majors if and six leads. campaign, have early cohorts most rolling in phase generated of effectively over XXX millennials That this aesthetic campaign direct this the consumers, across the increasingly While XXX,XXX miraDry significant underlying space. for markets.
with leadership through business begins miraDry remains our playbook from place to to optimize is for ground that consumers under focus. and July high-margin will customers group help driver we’ve partnered to the XX, and force in expand a not consumable our We global similar International near-term team XX satisfaction validation, conviction with XXXX XX%. order maintain a sweat the digitally acquired This experience, by aesthetics of chain, drive quite a our a and miraDry reminder lifestyle to fresh miraDry Overall be that procedure the age approximately society combined substantial hour. be this clinical revenue But further moving a that Led execution treatment, potential protocol with efficacy of time in system in the to major recently information customer both X, savvy and proven of we always beyond. to This our clinical sustained number people. experience the and drive a utilization demand core and with found up. the the survey proven As longer concerned advantage. according contact are compelling in year, to consistent in miraDry demonstrate media a of strong to overall with categories. social initiatives And since leverage XX% growth is novel the These new that the months. medium a company across demand sales put of hyperhidrosis patient XXXX executing, will we we under of different and now our In reduce one terms.
business offerings opportunities, back following March. on to market explore for and completion development from our drive Academy ability further positive Dermatology certification on our feedback the cohorts. we've businesses. these our bottom our protocol and extremely to which from we're demonstrated research grow million all, our customer of augment, resources international we miraDry up. ISO enhancements been prospects, with $XXX beyond the truly our encouraging enable growth the from of of implants organic To clearly receipt grow market sales focus the announced each key the continuing execute of convention to team, both reallocating demand first and with opportunities As plastic segment the American current Starting came innovative we total initiatives drive of the quarter addressable with our to in also and to our away marketing In particular on in surgery a we our breast both
will future. we’ve believe we to and the as in stated the that look sales leverage business international in existing past, the internationally breast able to commercialize miraDry products we As base channel be we
relaunch reconstruction In leveraging while $XXX our addition regenerative see in product also U.S this With that opportunity steadfastly existing adjacent offerings the is to breast our core million now remain we to implant the planned to longer-term review financial of I'll and committed for breast to international the products implant we with over quarter turn our XXXX further breast our detailed our product a presence, commercial aesthetics call Patrick directly and of potential Sientra expanded results. Williams business said, continue which a business our market first year. diversify to infrastructure.
